Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
WuXi Biologics Commenced Construction of 1.6 million sq. ft. Biologics Innovation Center in Shanghai 2018-11-22 14:31
WuXi Biologics' Chief Executive Officer Dr. Chris Chen to Serve on Board of Directors at ISPE and Delivered Keynote Speech at 2018 Annual Meeting 2018-11-07 17:51
WuXi Biologics Commenced Construction of 48,000L Biologics Commercial Manufacturing Center in Shijiazhuang 2018-10-31 16:08
WuXi Biologics Congratulates Tychan on Completing Human Safety Studies for the First-in-Class Zika Virus Antibody in Record Speed 2018-10-29 20:10
CANbridge Pharmaceutical and WuXi Biologics Enter into Strategic Partnership for Rare Disease Therapeutics 2018-10-23 20:00
I-Mab Biopharma Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody(TM) Platform for Three Bispecific Antibody Programs 2018-09-26 19:24
WuXi Biologics Appoints Harvard Professor David R. Liu to Scientific Advisory Board 2018-09-25 08:00
WuXi Biologics Appoints Harvard Professor David R. Liu to Scientific Advisory Board 2018-09-25 08:00
WuXi Biologics' Chief Quality Officer Received Foreign Post Service Award from FDA 2018-09-18 08:08
WuXi Biologics and Inhibrx Enter an Exclusive Partnership for GMP Manufacturing 2018-09-11 08:38
WuXi Biologics Selected into the Hang Seng HK 35 Index 2018-08-30 10:08
WuXi Biologics Reports Robust 2018 Interim Results 2018-08-20 20:25
WuXi Biologics Commenced Process Validation in MFG2 2018-07-31 07:55
WuXi Biologics Announced Successful Completion of the First cGMP Run in MFG3 2018-07-25 07:55
WuXi Biologics and Immune Pharmaceuticals Announce Late-Phase Development and Manufacturing Partnership for a First-In-Class Monoclonal Antibody 2018-07-09 22:00
WuXi Biologics and Harbour BioMed Announce Strategic Development and Manufacturing Partnership 2018-06-25 07:55
WuXi Biologics Initiated Construction of a State-of-the-Art Integrated ADC Solution Center 2018-06-20 08:03
WuXi Biologics to Invest $60 Million to Establish a Biologics Production Facility in the United States 2018-06-11 08:34
WuXi Biologics and Tsinghua University Innovation Center for Immune Therapy Sign MOU and Announce Strategic Partnership 2018-05-30 08:34
WuXi Biologics to Invest S$80 Million to Establish a Biologics Manufacturing Facility in Singapore 2018-05-22 18:34
1 6 7 8 9 10